Previous close | 5.80 |
Open | 5.75 |
Bid | 5.80 x 46300 |
Ask | 5.90 x 43700 |
Day's range | 5.75 - 5.85 |
52-week range | 2.16 - 6.65 |
Volume | |
Avg. volume | 238 |
Market cap | 141.397M |
Beta (5Y monthly) | 1.04 |
PE ratio (TTM) | 7.80 |
EPS (TTM) | 0.75 |
Earnings date | 09 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Cipher Pharmaceuticals' (TSE:CPH) stock is up by a considerable 48% over the past three months. Given the company's...
Generally speaking, investors are inspired to be stock pickers by the potential to find the big winners. You won't get...
NEW YORK, Jan. 29, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cipher Pharmaceuticals Inc. (TSX: CPH; OTCQX: CPHRF), a specialty pharmaceutical company, has qualified to trade on the OTCQX® Best Market. Cipher Pharmaceuticals Inc. upgraded to OTCQX from the Pink® market. Cipher Pharmaceuticals Inc. begins trading today on OTCQX under the symbol “CPHRF.” U.S. investors can find c